Pending · due 10 Apr 2028
Rules 1.1.0 · as of 14 Sep 2026
Owen Scott Muir · Said 10 Apr 2023 · owen-0420
Quote
“Neuromodulation (especially accelerated TMS) will be a first-line treatment for depression in 5 years.”
Item 1 of 16 in the post 'Predictions About The Future' (2023-04-10), a bullet list the author introduces as 'A few outlandish predictions, so I can be on record in the future when anyone checks'. Claim: neuromodulation, especially accelerated TMS protocols, becomes a first-line depression treatment within 5 years (about 2028).
Intake
- EventA proposition written from a template on the asset, with a resolution criterion and a named public source, before the outcome is looked up. The same event resolves every person's items on it. Method ›
- A depression practice guideline lists TMS as a first-line treatment
- AreaOne of five topic classes: regulatory decisions, clinical trial outcomes, company and market outcomes, payer and policy, practice adoption. Every event has one area. Method ›
- Practice adoption
- DeadlineThe date by which the event must happen for the item to be true. It comes only from the person's words through the anchor table. Method ›
- 10 Apr 2028 AnchorThe fixed table that turns the person's own words ('by 2026', 'Q2', 'within two years') into a deadline. The coder never invents a date. Method › · “in 5 years”
- Probability
- 0.90 LexiconThe fixed five-bin table that turns a phrase into a probability. The strongest phrase in the claim sentence decides; coders never read tone. Method › · binOne of five lexicon steps: A 'will' 0.90, B 'probably' 0.70, C 'may' 0.50, D 'unlikely' 0.30, E 'never' 0.10. A stated number goes to the nearest bin for calibration only. Method › A · “will”
- Base rateThe probability a published external study gives an event of that class and stage, fixed at intake. Halved when the item window is shorter than the class median time to decision. Never learned from the ledger's own items. Method ›
- None in the table
- Tags
- retrospective
- Coder BCohen's kappa: agreement between two coders beyond chance, from -1 to 1. Reported for admit, event, deadline, bin and asserts from the second-coder match test. Method ›
- admittedA statement that passed intake: sincere, the person's own claim, forward-looking, inside the five areas, and not excluded by a reason code. Only admitted statements become items. Method › · event E-0013 · deadline 10 Apr 2028 · bin A
Registry entry
The American Psychiatric Association issues a practice guideline for major depressive disorder that lists TMS (including accelerated protocols) as a first-line treatment option.
TRUE on the publication date of an American Psychiatric Association practice guideline, or guideline update, for major depressive disorder that recommends TMS (any protocol, including accelerated protocols) or another non-ECT neuromodulation modality as a first-line treatment option, that is, as an initial treatment not conditioned on prior antidepressant failure. A draft for comment, a payer policy, or a recommendation limited to treatment-resistant depression is not adoption. Resolution source: the APA Practice Guidelines (psychiatryonline.org). FALSE at the deadline when no such APA guideline has been published.
Resolution source: American Psychiatric Association Practice Guidelines (psychiatryonline.org)
Readings: 'Neuromodulation (especially accelerated TMS)' resolves on TMS; another non-ECT neuromodulation modality listed as first-line for MDD also counts.; ECT does not count: its existing role in severe or psychotic depression is not the change the claim describes.; 'First-line treatment for depression' means the guideline lists the modality as an initial treatment option for MDD without requiring prior antidepressant failure; a listing only for treatment-resistant depression does not count.
How to read
Coder A
Resolution
- Effective deadlineAn item enters the score only when its deadline has passed and the outcome is true or false. A claim already known true still waits for its deadline. Method ›
- 10 Apr 2028
- Outcome1 if the registry event happened on or before the item's deadline, 0 if it did not. Written by a resolver who never sees p. Method ›
- not occurred · checked through 13 Sep 2026
- Resolver note
- Criterion: publication of an APA practice guideline or update for MDD that recommends TMS or another non-ECT neuromodulation modality as a first-line (initial, not conditioned on antidepressant failure) treatment. Checked 2026-09-13: the APA Clinical Practice Guidelines page lists as current guidelines Delirium (2025), Borderline Personality Disorder (2025), Eating Disorders (2023), Schizophrenia (2020), Alcohol Use Disorder (2018), antipsychotics in dementia (2016) and Psychiatric Evaluation of Adults (2015). Major Depressive Disorder appears only under Legacy Practice Guidelines as the 2010 edition, with no update or new edition listed. With no new APA MDD guideline, a first-line TMS listing has not occurred. The page also links third-party MDD guidelines (VA/DoD 2022, ACP 2023); these are not APA guidelines. psychiatryonline.org could not be opened (bot check).
- Evidence
How to read
Registry
Timeline
1 claim against 0 events in the field.
Practice adoption